Drug intelligence / Profile preview

picroside II

Development stage
Preclinical
Lead developer
Shandong University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Picroside II is an iridoid glycoside and a primary bioactive constituent of the traditional Chinese medicinal plant *Picrorhiza scrophulariiflora* (Hu Huang Lian). It is primarily recognized for its hepatoprotective, anti-inflammatory, and antioxidant activities. In the context of metabolic dysfunction-associated steatotic liver disease (MASLD), picroside II has been shown to alleviate hepatic steatosis and improve liver function by targeting the cuproptosis pathway. Specifically, it downregulates the expression of ferredoxin 1 (FDX1) and lipoic acid synthase (LIAS), which inhibits copper deposition and restores the lipoylation of dihydrolipoamide S-acetyltransferase (DLAT). Beyond liver disease, it has been studied for its potential neuroprotective effects in cerebral ischemia-reperfusion injury and other inflammatory conditions.

Other names
picroside 2picroside2picroside-26'-O-trans-feruloylcatalpol
02

Targets

GPI (Glucose-6-phosphate isomerase)ACOX1 (Peroxisomal acyl-CoA oxidase 1)

Beyond the preview

Go deeper on picroside II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on picroside II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call